In 2024, the National Health Insurance (NHI) Administration reported approximately 2.16 million patients with hyperglycemia in Taiwan. Among them, 1,774,698 people met the criteria for the Diabetes Quality Payment Service; of these, 1,136,516 actually received care. 1
Dividing the two yields a care rate of 64.0%. In other words, for every three eligible diabetic patients, one has not entered this care program. 1
2.16 Million People and 64%
This program is not new. The NHI has long promoted diabetes medical payment improvement schemes. Since October 2012, it has been called the "Diabetes Quality Payment Service," where physicians, nurses, and nutrition education teams provide examinations, testing, health education, and follow-ups. 1
The design goal of the system is clearly stated: diabetes cannot be cured; blood glucose can only be controlled for life to avoid complications. Timely and effective outpatient care can prevent hospitalization and reduce unnecessary medical expenditures.
The care rate has been steadily rising over the last three years. It was 60.9% in 2022, 62.4% in 2023, and 64.0% in 2024; the number of enrolled patients also increased from 1,623,434 to 1,774,698. 1
| 2022 | 60.9 | Enrolled: 1,623,434 |
|---|---|---|
| 2023 | 62.4 | 1700728 |
| 2024 | 64 | 1774698 |
Source: NHI "2024 National Health Insurance Monitoring Indicator Results Report," Indicator 2.2
Another set of figures illustrates that there is a much larger population outside this specific line. In 2024, there were approximately 2.16 million patients with hyperglycemia, of which about 1.59 million were enrolled in NHI chronic disease care programs (including metabolic plans, quality-based schemes, family medicine plans, regional hospital holistic community care plans, etc.), with a care rate of 73.4%. 1
The difference between the two care rates lies in the denominator: for the 64.0% rate, the denominator is "those meeting the criteria for the diabetes program," whereas for the 73.4% rate, the denominator is "patients with hyperglycemia." In the same year, the two metrics use different denominators: the former refers to the 1,774,698 people eligible for the diabetes program, while the latter refers to approximately 2.16 million patients with hyperglycemia; these are not the same group of people.
Who is Included: 70% in Regional Hospitals, 53% in Primary Clinics
Looking at different levels of care, the care rate in 2024 was highest in regional hospitals: regional hospitals at 70.8%, district hospitals at 66.4%, medical centers at 62.5%, and primary clinics at 53.5%. 1
The ranking by number of patients treated is completely different. Primary clinics treated 458,300 people, accounting for 40% of the total care recipients—the highest among the four levels; followed by regional hospitals with 307,931, district hospitals with 196,091, and medical centers with 191,650. 1
Source: NHI "2024 National Health Insurance Monitoring Indicator Results Report," Indicator 2.2
The NHI Administration speculates that the low care rate in primary clinics may be due to threshold requirements. This program works in conjunction with the Health Promotion Administration's (HPA) Diabetes Integrated Care Network, which requires institutions to form teams including not just physicians, but also nursing and nutrition education staff; for small general clinics or district hospitals, this threshold is relatively high. 1
The alternative pathway for primary care is a different mechanism. Since April 2016, the NHI Administration has promoted the "Scheme to Encourage Medical Institutions to Query Patient Medical Information in Real-Time," allowing institutions that cannot join the main program to perform regular patient follow-ups and upload test results—such as HbA1c, LDL, and microalbuminuria—to the cloud, for which the NHI pays a case management fee. 1
The capacity of this pathway is also growing. In 2024, 43,767 people completed regular follow-ups and test result uploads, an increase of 13,296 compared to the 30,471 in 2023. 1
The One-Third Not Caught
The National Health Insurance Review Board (NHIRB) states the gap very directly in its report: although the overall care rate has risen to 64% in 2024, approximately one-third of diabetes patients are still not included in relevant integrated care programs. They suggest that the NHI Administration analyze the characteristics and reasons for this group. 1
The weight of this statement lies in its positioning: it frames the problem as "who is not coming in" rather than "how well those who have entered are being cared for." For a disease requiring lifelong follow-up, not being enrolled means lacking institutional reminders, testing, and health education.
Since the report does not specify who this one-third consists of, the NHIRB recommends that the NHI Administration analyze their characteristics and causes. 1
Has the Hospitalization Rate Decreased?
Theoretically, a rising care rate should be reflected in the hospitalization rate. This report lists the "diabetes patient hospitalization rate" as an avoidable hospitalization indicator; the numerator is inpatient cases aged 15 and older with diabetes as the primary diagnosis, and the denominator is the population aged 15 and older. 1
From 2022 to 2024, the overall hospitalization rates were 0.12%, 0.13%, and 0.13%, appearing stable. 1
The distribution across age groups is highly uneven. For ages 15–24, it is 0.02% to 0.03%; for 25–34, it is also 0.02% to 0.03%; for 35–44, it remains steady at 0.05%; and for 45–54, it is 0.09% to 0.10%. 1
The highest hospitalization rates are in the 65–74 and 75+ age groups. The report notes that the 2024 hospitalization rates for these two age groups were slightly lower than in 2022 and 2023, suggesting this should be observed alongside the rising care rate. 1
Stability is not necessarily bad news. While the care rate rose from 60.9% to 64.0%, the hospitalization rate did not rise accordingly; however, saying "the rising care rate caused the decrease in hospitalization" is not yet supported by current data, as the hospitalization rate itself has barely moved over the three years. 1
The 2026 Integration
The next systemic change will occur in 2026. The NHI Administration plans to integrate diabetes (DM), early chronic kidney disease (CKD), and diabetic kidney disease (DKD) from the primary care quality-based schemes with the Family Physician Integrated Care Program. Patients enrolled in multiple programs will be unified under the family physician care plan. 1
The report's explanation of the 2023 integration was: to use medical groups and family physicians to detect metabolic syndrome patients early, assisting in case management and delaying the progression of chronic diseases. Regarding this 2026 integration, the report only states that it aims to improve care quality and implement holistic care. 1
For patients, the practical meaning of this change is not having to be enrolled in two separate programs simultaneously. For the system, it means consolidating follow-ups—which were previously split across three lines (diabetes, kidney disease, and family medicine)—into a single caregiver.
The Link to Dialysis
The effectiveness of the diabetes care network will ultimately be reflected in a much more distant place: dialysis.
The 2024 Taiwan Renal Year Book states that among new dialysis patients in 2022, 46.1% had diabetes as their primary diagnosis. 2 In that same year, there were 12,459 new dialysis cases and a dialysis prevalence of 88,555 people. 2
Looking at these two sets of numbers together makes the significance of the diabetes care rate clear: it is not just an outpatient metric, but an upstream indicator for dialysis incidence. A 64% care rate means there are still approximately 640,000 people (1,774,698 minus 1,136,516 equals 638,182) who meet the criteria but are not in this tracking system, and diabetes is the most common primary diagnosis for new dialysis cases (accounting for 46.1% in 2022). 12
Finding that one-third is harder than pushing the care rate of those already enrolled from 64% to 70%, but its impact on the number of dialysis cases could be much greater.
Further Reading:
- Emergency Room Congestion — When chronic diseases are poorly controlled, the ER is the first point of contact
- Taiwan Healthcare and National Health Insurance — Global budgets, point values, and the upstream of chronic disease care schemes
- Development of Taiwan's Long-Term Care System — The next stage of care after disability caused by diabetes complications
References
- 2024 National Health Insurance Monitoring Indicator Results Report (National Health Insurance Review Board, Ministry of Health and Welfare, November 2025) — Official annual monitoring report. Indicator 2.2 specifies the 2022–2024 Diabetes Quality Payment Service care rates (overall 60.9%, 62.4%, 64.0%; medical centers 62.5%, regional hospitals 70.8%, district hospitals 66.4%, primary clinics 53.5%), care and enrollment numbers, explanations of primary care thresholds, and the 2026 integration plan for DM/CKD/DKD and family medicine; Indicator 3.2 specifies diabetes patient hospitalization rates (0.12%, 0.13%, 0.13%) and age distribution; the report also notes approximately 2.16 million patients with hyperglycemia, about 1.59 million enrolled in chronic disease care programs with a 73.4% rate, 43,767 people completing regular follow-up uploads, and the NHIRB's analysis regarding "approximately one-third not included."↩234567891011121314151617181920
- 2024 Taiwan Renal Year Book (National Health Research Institutes, Taiwan Society of Nephrology) — The yearbook summary states that in 2022, 46.1% of new dialysis patients had diabetes as their primary diagnosis, with 12,459 new dialysis cases and a dialysis prevalence of 88,555 people.↩23